Funding round pulls in $8.5M for Ocular Therapeutix

06/11/2013 | Medical Device & Diagnostic Industry online

Ocular Therapeutix has secured $8.5 million in a funding round, according to a regulatory filing. The Bedford, Mass.-based company is awaiting premarket approval from the FDA for its ReSure Sealant, a biocompatible hydrogel used to help protect corneal incisions in patients who have undergone intraocular lens placement or cataract procedures.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA